Dynavax Technologies Corp Files DEFA14A Proxy Statement
| Field | Detail |
|---|---|
| Company | Dynavax Technologies Corp |
| Form Type | DEFA14A |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, governance
TL;DR
DYNA filed its proxy statement, no fee needed. Standard shareholder info.
AI Summary
Dynavax Technologies Corporation filed a DEFA14A on May 23, 2025, related to its proxy statement. The filing indicates no fee was required for this submission. The company is incorporated in Delaware and its fiscal year ends on December 31st.
Why It Matters
This filing is a routine regulatory submission for Dynavax Technologies Corporation, providing shareholders with information related to proxy voting and corporate governance.
Risk Assessment
Risk Level: low — This filing is a standard DEFA14A proxy statement, which is a routine regulatory disclosure and does not inherently present new risks.
Key Players & Entities
- DYNAVAX TECHNOLOGIES CORP (company) — Registrant
- 20250523 (date) — Filing Date
- DEFA14A (document_type) — Filing Type
- 0001193125-25-125825 (accession_number) — SEC Accession Number
- 2834 (sic_code) — Standard Industrial Classification
- DE (state) — State of Incorporation
- 1231 (fiscal_year_end) — Fiscal Year End
- 001-34207 (sec_file_number) — SEC File Number
- 25981978 (film_number) — Film Number
- 2100 POWELL STREET SUITE 720 (address) — Business and Mail Address
FAQ
What type of filing is Dynavax Technologies Corporation submitting?
Dynavax Technologies Corporation is submitting a DEFA14A, which is a Definitive Additional Materials filing related to its proxy statement.
When was this DEFA14A filing made?
The DEFA14A filing was made on May 23, 2025.
Is there a filing fee associated with this DEFA14A?
No, the filing indicates that no fee is required for this submission.
What is Dynavax Technologies Corporation's Standard Industrial Classification (SIC) code?
Dynavax Technologies Corporation's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Dynavax Technologies Corporation incorporated and what is its fiscal year end?
Dynavax Technologies Corporation is incorporated in Delaware (DE) and its fiscal year ends on December 31st (1231).
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 23, 2025 regarding DYNAVAX TECHNOLOGIES CORP.